共 50 条
- [1] Institutional experience in induction chemotherapy and neoadjuvant IMRT for borderline resectable and locally advanced pancreatic adenocarcinomaANNALS OF ONCOLOGY, 2015, 26de Torres Olombrada, M. V.Garcia Canibano, T.Juez Martel, I.Gutierrez Abad, D.Pereira Perez, F.Ludena Martinez, B.
- [2] Outcomes of Neoadjuvant Chemoradiation With and Without Systemic Chemotherapy in Resectable and Borderline Resectable Pancreatic AdenocarcinomaFRONTIERS IN ONCOLOGY, 2020, 10Trinh, Katherine, VFischer, Dawn A.Gardner, Timothy B.Smith, Kerrington D.
- [3] OUTCOMES OF NEOADJUVANT CHEMORADIATION WITH AND WITHOUT SYSTEMIC CHEMOTHERAPY IN RESECTABLE AND BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMAGASTROENTEROLOGY, 2019, 156 (06) : S324 - S325Trinh, Katherine V.Fischer, Dawn A.Gardner, Timothy B.Smith, Kerrington
- [4] Survival After Neoadjuvant Chemotherapy in Borderline Resectable Disease is Similar to That of Upfront Resectable Pancreatic AdenocarcinomaANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S150 - S150Chawla, A.Molina, G.Pak, L.Wang, J.
- [5] Predictors of Undergoing Surgical Resection after Neoadjuvant Chemoradiotherapy for Borderline Resectable and Resectable Pancreatic AdenocarcinomaINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E63 - E64Neibart, S. S.Mamidanna, S.Chundury, A.Sayan, M.Alexander, H. R.August, D.Berim, L. D.Boland, P. M.Grandhi, M. S.Gulhati, P.Kennedy, T. J.Langan, R. C.Spencer, K.Jabbour, S. K.
- [6] Efficacy of Neoadjuvant Chemotherapy and Radiation in Resectable/Borderline Resectable Pancreatic Ductal AdenocarcinomaANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S176 - S177Kelley, Jesse K.Kolbeinsson, HordurEastburg, BenjaminFrisch, AustinKhan, MariamWright, Gerald P.Assifi, MuraChandra, SreenivasaChung, Mathew
- [7] Factors associated with Failure to Reach Surgical Resection in Patients undergoing Neoadjuvant Chemotherapy for Resectable and Borderline Resectable Pancreatic Head AdenocarcinomaANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S177 - S177Gleisner, A. L.Miller, J. L.Assifi, M.Steve, J. Y.Bartlett, D. L.Hogg, M. E.Zeh, H. J.Zureikat, A. H.
- [8] Neoadjuvant chemotherapy improves outcomes in resectable pancreatic adenocarcinomaSURGERY IN PRACTICE AND SCIENCE, 2022, 11Christopher, WadeNassoiy, SeanMarcus, RebeccaKeller, JenniferChang, Shu-ChingFischer, TrevanBilchik, AntonGoldfarb, Melanie
- [9] Sequential neoadjuvant chemotherapy for borderline resectable and locally advanced pancreatic adenocarcinomaJOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Paluri, Ravi KumarMcCormack, Michael Joseph, Jr.Neal, AustinMoore, StacieShen, PerryClark, ClancyOgburn, OliviaDressler, Emily Van MeterDeep, GaganGreissinger, AprilMcilwain, LauraYacoub, GeorgeSirkisoon, SheronaLima, Caio Max Sao Pedro Rocha
- [10] Use and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australasian populationASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 (01) : 214 - 225Walpole, ImogenLee, BelindaShapiro, JeremyThomson, BenjaminLipton, LaraAnanda, SumitraUsatoff, ValMclachlan, Sue-AnnKnowles, BrettFox, AdrianWong, RachelCooray, PrasadBurge, MatthewClarke, KatePattison, SharonNikfarjam, MehrdadTebbutt, NiallHarris, MarionNagrial, AdnanZielinski, RobChee, Cheng EanGibbs, Peter